D. Martineau et al., Functional involvement of angiotensin AT(2) receptor in adrenal catecholamine secretion in vivo, CAN J PHYSL, 77(5), 1999, pp. 367-374
The aim of the present study was to analyse modulations of adrenal catechol
amine secretion from the adrenal gland of anesthetized dogs in response to
locally administered angiotensin II (AngII) in the presence of either PD 12
3319 or CGP 42112, both of which are highly specific and selective ligands
to angiotensin AT(2) receptor. Plasma concentrations of epinephrine and nor
epinephrine in adrenal venous and aortic blood were quantified by a high pe
rformance liquid chromatography coupled with electrochemical detection (HPL
C-EC) method. Adrenal venous blood flow was measured by gravimetry. Local a
dministration of AngII (0.05 mu g, 0.1 mu M) to the left adrenal gland incr
eased adrenal gland catecholamine output more than 30 times that found in n
onstimulated states. Administration of either PD 123319 (0.085 mu g (0.23 m
u M) to 8.5 mu g (23 mu M)) or CGP 42112 (0.005 mu g (0.01 mu M) to 5 mu g
(10 mu M)) did not affect the basal catecholamine output significantly. The
increase in adrenal catecholamine output in response to AngII was inhibite
d by similar to 80% following the largest dose of PD 123319. CGP 42112 sign
ificantly attenuated the catecholamine response to AngII by similar to 70%.
PD 123319 and CGP 42112 were devoid of any agonist actions with respect to
catecholamine output by the adrenal gland in vivo. Furthermore, both PD 12
3319 and CGP 42112 inhibited the increase in adrenal catecholamine secretio
n induced by local administration of AngII. The present study suggests that
AT(2) receptors play a role in mediating catecholamine secretion by the ad
renal medulla in response to AngII receptor agonist administration in vivo.